QuidelOrtho financials
$10.60−2.17%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 28 | FY24 Dec 29 | FY23 Dec 31 | FY22 Jan 1 |
|---|---|---|---|---|
| Revenue | $2.73B | $2.78B | $3.00B | $3.27B |
| Gross profit | $1.27B | $1.29B | $1.50B | $1.94B |
| Gross margin | 46.7% | 46.2% | 49.9% | 59.3% |
| Operating income | -$919.2M | -$1.96B | $139.1M | $979.7M |
| Net income | -$1.13B | -$2.05B | -$10.1M | $548.7M |
| Net margin | −41.5% | −73.7% | −0.3% | 16.8% |
| Diluted EPS | $-16.69 | $-30.54 | $-0.15 | $9.56 |
| EBITDA | $496.8M | $499.2M | $714.2M | $1.27B |
| Operating cash flow | $105.2M | $83.0M | $280.2M | $885.3M |
| Free cash flow | -$83.0M | -$112.1M | $70.9M | $744.4M |
| Diluted shares | 67.8M | 67.2M | 66.8M | 57.4M |
Balance sheet
| Period end | Dec 28 | Dec 29 | Dec 31 | Jan 1 |
|---|---|---|---|---|
| Cash & equivalents | $169.8M | $98.3M | $118.9M | $292.9M |
| Short-term investments | $0.00 | $0.00 | $48.4M | $52.1M |
| Total debt | $2.65B | $2.48B | $2.41B | $2.64B |
| Total assets | $5.77B | $6.42B | $8.56B | $8.86B |
| Total liabilities | $3.85B | $3.44B | $3.56B | $3.92B |
| Shareholders' equity | $1.92B | $2.98B | $5.01B | $4.93B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology